Dear John,

ICYMI, Jonathan Perlin of The Joint Commission appeared on A Health Podyssey to discuss the origins of this commission, the impacts made on health care through quality improvement and patient safety, the role of accreditation, the public policy levers that drive change, and more.

This week, Robert F. Kennedy Jr. announced that the Department of Health and Human Services would be cancelling $500 million in projects focused on vaccine development.

For today's Flashback Friday, let's take a look at what Health Affairs has published on the topic of vaccine development and biomedical research.

Four Opportunities To Revitalize The US Biomedical Research Enterprise

E. Albert Reece et al. (January 2025)

COVID-19 Vaccines: Moderna And Pfizer-BioNTech Use Varied By Urban, Rural Counties

Katherine Wen et al. (May 2024)

Global Vaccine Access Demands Combating Both Inequity And Hesitancy

Peter J. Hotez (December 2023)

The Future Of COVID-19 Vaccine Development

Florian Krammer (October 2023)

Vaccine Development After The COVID-19 Pandemic: Are Programs And Policies Ready To Embrace Innovation?

Angela K. Shen et al. (February 2023)

Today's Featured Articles

Medicare Physicians Are Getting a Raise...But At What Cost?

Jeff Byers welcomes Senior Editor Leslie Erdelack back to the pod to discuss the proposed rule change to the Medicare Physician Fee Schedule for 2026, which includes payment conversion factors for doctors, alternative payment models, add-on codes for Advanced Primary Care Management services, and more.

Beyond The Bill: The Hidden Economic Toll Of High Commercial Provider Prices

Daniel R. Arnold

part of our Provider Prices In The Commercial Sector series

340B w/ Sayeh Nikpay

Join Health Affairs on August 20 for an exclusive Insider virtual event breaking down the 340B program with Sayeh Nikpay.

Become an Insider for $180 annually to get access to exclusive events, our trend reports, and monthly newsletters.